(Total Views: 590)
Posted On: 05/05/2020 9:57:16 AM
Post# of 154874
Updated NYP
An experimental HIV drug that has been used to successfully treat COVID-19 patients is in its second phase of testing with the Food and Drug Administration and could potentially be approved for use in four weeks, its manufacturer says.
Leronlimab, made by the biotech company CytoDyn, was used to treat a handful of severely ill patients in New York City hospitals; a couple were able to be removed from their ventilators.
“I think the FDA will be willing to work with us,” CytoDyn CEO Nader Pourhassan told The Post. “I am hoping it will be expedited … I don’t see how the FDA couldn’t approve it.”
https://nypost.com/2020/04/04/hiv-drug-that-t...SxQUThwa9I
An experimental HIV drug that has been used to successfully treat COVID-19 patients is in its second phase of testing with the Food and Drug Administration and could potentially be approved for use in four weeks, its manufacturer says.
Leronlimab, made by the biotech company CytoDyn, was used to treat a handful of severely ill patients in New York City hospitals; a couple were able to be removed from their ventilators.
“I think the FDA will be willing to work with us,” CytoDyn CEO Nader Pourhassan told The Post. “I am hoping it will be expedited … I don’t see how the FDA couldn’t approve it.”
https://nypost.com/2020/04/04/hiv-drug-that-t...SxQUThwa9I
(0)
(0)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
